Search VASO
VASO Corp
OTC · CIK 839087
Last close0.3
Daily change+0.01 (3.45%)
10 Years gain+114.29%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
VASO · STANDARD
SIC 3845 · Electromedical & Electrotherapeutic Apparatus · Fiscal year end 1231
Fundamental
38.0Momentum
n/aAcceleration
n/aConfidence
66.0Annual Revenue16
Quarterly Revenue50
Annual CFO13
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth4.3 / 25
Quality15.6 / 25
Capital Efficiency0.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators3.0 / 5
Signals
Share count reductionDiluted share count declined 99.8997%.
Key Metrics
Revenue Growth TTM2.84%OK
Revenue CAGR 3Y3.96%OK
Gross Marginn/aMISSING
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-99.9%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $89.10M | $54.67M | -$2.89M | $9.27M | n/a | 61.36% | -3.24% | n/a | n/a | 176M |
| 2025 FY Dec 31, 2024 | $86.77M | $52.05M | $285,000.00 | $3.28M | n/a | 59.99% | 0.33% | n/a | 14.37% | 175.59M |
| 2024 FY Dec 31, 2023 | $81.02M | $50.59M | $4.20M | $5.30M | n/a | 62.44% | 5.18% | n/a | 250.65% | 175.54M |
| 2023 FY Dec 31, 2022 | $79.29M | $47.90M | $6.45M | $14.42M | n/a | 60.41% | 8.14% | n/a | 135.17% | 174.66M |
| 2022 FY Dec 31, 2021 | n/a | $43.13M | $2.82M | $7.82M | $7.40M | n/a | n/a | n/a | n/a | 173.77M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $81.43M | sum latest 4 fiscal quarters Revenue | OK | 0001213900-26-057690, 0001213900-25-076616 |
| Revenue Growth TTM | 2.84% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001213900-26-057690, 0001213900-25-076616 |
| Revenue CAGR 3Y | 3.96% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001213900-26-037664 |
| Revenue CAGR 5Y | 4.99% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001213900-26-037664 |
| Gross Profit CAGR 3Y | 4.51% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001213900-26-037664 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | derived |
| Current Ratio | 1.67x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $462.81 | Revenue / Diluted Shares | OK | 0001213900-26-057690, 0001213900-25-076616 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001213900-26-037664 |
| Diluted EPS TTM | n/a | Net income TTM / Diluted shares | NOT_MEANINGFUL | 0001213900-26-057690 |
| Gross Margin Delta 1Y | n/a | GrossMargin_current - GrossMargin_prior_year | INSUFFICIENT_HISTORY | derived |